Aktiengesellschaft Bayer's Net Worth
$2.33 Billion
Who is Aktiengesellschaft Bayer?
Aktiengesellschaft Bayer has an estimated net worth of $2.33 Billion. This is based on reported shares across multiple companies, which include Azitra Inc, Elanco Animal Health Inc, Century Therapeutics, Inc., CRISPR Therapeutics AG, Pyxis Oncology, Inc., and Senti Biosciences, Inc..
SEC CIK
Aktiengesellschaft Bayer's CIK is 0001144145
Past Insider Trading and Trends
2021 was Aktiengesellschaft Bayer's most active year for acquiring shares with 4 total transactions. Aktiengesellschaft Bayer's most active month to acquire stocks was the month of May. 2021 was Aktiengesellschaft Bayer's most active year for disposing of shares, totalling 4 transactions. Aktiengesellschaft Bayer's most active month to dispose stocks was the month of May. 2021 saw Aktiengesellschaft Bayer paying a total of $15,000,000.00 for 15,418,176 shares, this is the most they've acquired in one year. In 2020 Aktiengesellschaft Bayer cashed out on 54,500,000 shares for a total of $1,626,367,200.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Azitra Inc (AZTR) Snapshot price: $0.9601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.31M |
—
|
—
| 1.31M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Elanco Animal Health Inc (ELAN) Snapshot price: $15.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -74.71% | -54.50M |
$29.84 | -$1,626,367,200.00 | 18.45M |
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Century Therapeutics, Inc. (IPSC) Snapshot price: $4.56
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.68M |
$20.00 |
—
| 12.68M |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CRISPR Therapeutics AG (CRSP) Snapshot price: $65.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.33% | 527.47K |
$22.75 | $11,999,988.00 | 5.63M |
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pyxis Oncology, Inc. (PYXS) Snapshot price: $3.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.74M |
—
|
—
| 2.74M |
Oct 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |